High-efficient lentiviral vector-mediated gene transfer into primary human NK cells

Experimental Hematology

Volumn 34, Issue 10, 2006, Pages 1344-1352

  Micucci, Federica ^a   Zingoni, Alessandra ^a   Piccoli, Mario ^a   Frati, Luigi ^a   Santoni, Angela ^a   Galandrini, Ricciarda ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; ELONGATION FACTOR 1ALPHA; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2; LENTIVIRUS VECTOR; RECEPTOR;

ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; NATURAL KILLER CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TECHNIQUE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; GENES, REPORTER; GENETIC VECTORS; HUMANS; INTERLEUKIN-12; KILLER CELLS, NATURAL; LENTIVIRUS; LYMPHOCYTE ACTIVATION; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS (GENETICS); TIME FACTORS; TRANSDUCTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33748568194     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.06.001     Document Type: Article

References (34)

1. Hamerman J.A., Ogasawara K., and Lanier L.L. NK cells in innate immunity. Curr Opin Immunol 17 (2005) 29-35
2. Billadeau D.D., Mackie S.M., Schoon R.A., et al. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity. J Exp Med 192 (2000) 381-392
3. Galandrini R., Micucci F., Tassi I., et al. Arf6: a new player in FcγRIIIA lymphocyte-mediated cytotoxicity. Blood 106 (2005) 577-583
4. Schroers R., Hildebrandt Y., Hasenkamp J., et al. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Exp Hematol 32 (2005) 536-546
5. Galandrini R., Tassi I., Morrone S., et al. The adaptor protein shc is involved in the negative regulation of NK cell-mediated cytotoxicity. Eur J Immunol 31 (2001) 2016-2025
6. Becknell B., Trotta R., Yu J., et al. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. J Immunol Methods 296 (2005) 115-123
7. Guven H., Konstantinidis K., Alici E., et al. Efficient gene transfer into primary human natural killer cells by retroviral transduction. Exp Hematol 33 (2005) 1320-1328
8. Wiznerowicz M., and Trono D. Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol 23 (2005) 42-47
9. Bukrinsky M.I., Sharova N., Dempsey M.P., et al. Active nuclear import of human immunodeficiency virus type 1 preintegration complex. Proc Natl Acad Sci U S A 89 (1992) 6580-6584
10. Naldini L., and Blomer U. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (2006) 263-267
11. Weinberg J.B., Matthews T.J., Cullen B.R., and Malom M.H. Productive human immunodeficiency virus type 1 (HIV-1) infection of non proliferating human monocytes. J Exp Med 174 (1991) 1477-1482
12. Salmon P., Kindler V., Ducrey O., Chapuis B., Zubler R.H., and Trono D. High-level transgene expression in human hematopoietic progenitor and differentiated blood lineage after transduction with improved lentiviral vectors. Blood 96 (2000) 3392-3398
13. Bay Y., Soda Y., Izawa K., et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Gene Ther 10 (2003) 1446-1457
14. Puthenveetil G., Scholes J., Carbonell D., et al. Successful correction of the human β-thalassemia major phenotype using a lentiviral vector. Blood 104 (2004) 3445-3453
15. Muhlebach M., Wolfrum N., Schule S., et al. Stable transduction of primary human monocytes by simian lentiviral vector PBj. Mol Ther 12 (2005) 1206-1216
16. Tan P.H., Beutelspacher S.C., Xue S.-A., et al. Modulation of human dendritic-cell function following transduction with viral vectors: implication for gene therapy. Blood 105 (2005) 3824-3832
17. Zufferey R., Dull T., Mandel R.J., et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72 (1998) 9873-9880
18. Stauffer T.P., Ahn S., and Meyer T. Receptor-induced transient reduction in plasma membrane PtdIns(4, 5)P2 concentration monitored in living cells. Curr Biol 8 (1998) 343-346
19. Fassett M.S., Davis D.M., Valter M.M., Cohen G.B., and Strominger J.L. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc Natl Acad Sci U S A 98 (2001) 14547-14552
20. Miller J.S., Soignier Y., Panaskaltsis-Mortari A., et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105 (2005) 3051-3057
21. Ducrey-Rundquist O., Guyader M., and Trono D. Modalities of interlukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J Virol 76 (2002) 9103-9111
22. Bottino C., Castriconi R., Moretta L., and Moretta A. Cellular ligands of activating NK receptors. Trends Immunol 26 (2005) 221-226
23. Tang S., Patterson B., and Levy J.A. Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation. J Virol 69 (1995) 5659-5665
24. Stevenson M., Stanwick T.L., Dempsey M.P., and Lamonica C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 9 (1990) 1551-1560
25. Zack J.A., Haislip A.M., Krogstad P., and Chem I.S. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 66 (1992) 1717-1725
26. Kinoshita S., Chen B.K., Kaneshima H., and Nolan G.P. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95 (1998) 595-604
27. Unutmaz D., KewalRamani V.N., Marmon S., and Littman D.R. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 189 (1999) 1735-1746
28. Dardalhon V., Jaleco S., Kinet S., et al. IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells. Proc Natl Acad Sci U S A (2001) 989277-989282
29. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 (2003) 133-146
30. Chan S.H., Kobayashi M., Santoli D., Perussia B., and Trinchieri G. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). J Immunol 148 (1992) 92-98
31. Hodge D.L., Martinez A., Julias J.G., Taylor L.S., and Young H.A. Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control. Mol Cell Biol 22 (2002) 1742-1753
32. Cavalieri S., Cazzaniga S., Geuna M., et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competent. Blood 103 (2003) 497-505
33. Liu J.W., Pernod G., Dunoyer-Geindre S., et al. Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells 24 (2006) 199-208
34. Shibuya K., Shirakawa J., Kameyama T., et al. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med 198 (2003) 1829-1839